-
Listing
-
Trading
Where European Government Bonds meet the futureFixed Income derivativesLes merTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLes merEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLes merEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Les merThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Les merShaping capital markets for future generations
Bell Ceremony to welcome the 2014 European Biotech Week in Brussels
08/10/2014
On 8 October 2014, Nathalie Moll, Secretary General of EuropaBio rang the Opening Bell together with Karin Baudin, VP Technology Transfer InsermTransfert of ENTENTE Project at Euronext Brussels. At this event, the partners of the ENTENTE-project together with the European Commission and EuropaBio announced on the podium the 5th Most Innovative European Biotech SME Award and the ENTENTE Life Sciences Investment Forum, which are taking place during the 2014 European Biotech Week in Brussels.
Ruxandra Draghia-Akli, Director, Directorate Health at DG Research and Innovation of the European Commission has held a short speech as well during the Bell Ceremony.
To know more : www.biotechweek.org